SB
Subrata Banerjee
About Subrata Banerjee
Data last updated:
Subrata Banerjee is a Director at Criceto Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Criceto Pharmaceuticals Private Limited reported revenue of ₹1.36 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Criceto Pharmaceuticals Private Limited U24290AS2021PTC021111 | Director | 15 Jul 2023 | 2021 | ₹1.36 Cr (FY 2025) | Active |
Board colleagues of Subrata Banerjee
| Name | DIN | Company | Designation |
|---|---|---|---|
| Chandrima Banerjee | 09100088 | Criceto Pharmaceuticals Private Limited | Director |
| Jaydip Bhowmick | 10235269 | Criceto Pharmaceuticals Private Limited | Director |
| Rimi Paul | 09100087 | Criceto Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Subrata Banerjee
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Subrata Banerjee
Subrata Banerjee currently holds 1 directorship: Criceto Pharmaceuticals Private Limited (Director, since 15 Jul 2023, revenue ₹1.36 Cr (FY 2025)).
Subrata Banerjee was first appointed on 15 Jul 2023 as Director at Criceto Pharmaceuticals Private Limited.
The current boards of Subrata Banerjee's companies include Chandrima Banerjee (Criceto Pharmaceuticals Private Limited), Jaydip Bhowmick (Criceto Pharmaceuticals Private Limited), Rimi Paul (Criceto Pharmaceuticals Private Limited).